FLUENCY® PLUS in the Treatment of Peripheral Artery Disease

CompletedOBSERVATIONAL
Enrollment

146

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

February 28, 2022

Conditions
Vascular Diseases, Peripheral
Interventions
DEVICE

Endovascular revascularization of peripheral arteries

Endovascular revascularization of peripheral arteries involves placement of a self-expanding Nitinol Stent encapsulated with ePTFE in diseased vessel segments

Trial Locations (6)

20246

Universitätsklinikum Hamburg-Eppendorf, Hamburg

92637

Klinikum Nordoberpfalz AG - Klinikum Weiden, Weiden

93053

Universitätsklinikum Regensburg, Regensburg

80-214

Medical University of Gdańsk, Gdansk

07-410

Mazowiecki Szpital Specjalistyczny (MSS Ostroleka), Ostrołęka

03-242

Mazowiecki Szpital Brodnowski, Warsaw

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cromsource

INDUSTRY

lead

C. R. Bard

INDUSTRY

NCT04765566 - FLUENCY® PLUS in the Treatment of Peripheral Artery Disease | Biotech Hunter | Biotech Hunter